SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Trading Update

25 Nov 2021 07:00

RNS Number : 5078T
Forterra plc
25 November 2021

25 November 2021

FORTERRA PLC

Trading Update: Continued Strong Performance

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update covering the four months ended 31 October 2021 (the "period").

Headlines

Strong trading performance in the period with brick sales volumes up 6% vs 2019 leaving YTD brick sales volumes in line with 2019

Significant cost inflation experienced across a range of categories including energy, raw materials and transportation. c90% of energy requirement secured for remainder of the year

Concrete product selling price increases to recover cost inflation have already been achieved with significant brick price increases secured from 1 January 2022

Accordingly, we expect to deliver a 2021 result in line with management's expectations

Strong market demand has meant that inventory levels remain at very low levels

Short term impact on margins experienced due to cost inflation in 2021, but selling price increases are expected to benefit margins in 2022

Positive market demand dynamics looking into 2022 although business remains broadly capacity constrained until Desford brick factory commissioning

Around 60% of total energy requirements secured for 2022 with c85% secured for Q1 when risk of volatility is greatest

Desford and Wilnecote expansion projects progressing according to plan with commissioning of Desford expected in Q4 2022, within 拢95m budget

Stephen Harrison, Chief Executive of Forterra plc commented:

"The strong trading seen in the both the housebuilding and repair maintenance and improvement (RM&I) markets in first half of the year continued into the second half. As expected, we encountered significant pressures across our supply chain in the period, although, due to the agility of our operational management, we have been successful in limiting any disruption. We also experienced meaningful input cost inflation, which has had a short-term impact on margins, however we are mitigating this through significant selling price increases. Notwithstanding these factors, we continue to anticipate delivering a full year result in line with management's expectations, with higher than expected revenues offsetting the increased cost base.

"Heading into 2022 we are optimistic about the continuing buoyant demand for our products, underpinned by favourable market fundamentals. With the brick capacity uplift provided by the new Desford brick factory now only a year away, and with the Wilnecote project increasing our presence in the commercial and specification market from 2023, we are confident that Group performance will continue to strengthen."

ENQUIRIES

Forterra plc +44 1604 707 600

Stephen Harrison, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTBLBDBDSDDGBS

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS